Wellington Management Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
359,451
+54,921
| +18% | +$198K | ﹤0.01% | 1668 |
|
|
2025
Q1 | $911K | Buy |
304,530
+86,021
| +39% | +$257K | ﹤0.01% | 1719 |
|
|
2024
Q4 | $732K | Sell |
218,509
-3,053
| -1% | -$10.2K | ﹤0.01% | 1761 |
|
|
2024
Q3 | $742K | Sell |
221,562
-33,604
| -13% | -$113K | ﹤0.01% | 1748 |
|
|
2024
Q2 | $845K | Sell |
255,166
-94,838
| -27% | -$314K | ﹤0.01% | 1702 |
|
|
2024
Q1 | $1.41M | Buy |
+350,004
| New | +$1.41M | ﹤0.01% | 1601 |
|
|
2023
Q2 | – | Sell |
-286,233
| Closed | -$959K | – | 1816 |
|
|
2023
Q1 | $959K | Sell |
286,233
-11,507
| -4% | -$38.5K | ﹤0.01% | 1669 |
|
|
2022
Q4 | $1.43M | Buy |
297,740
+69,775
| +31% | +$336K | ﹤0.01% | 1574 |
|
|
2022
Q3 | $1.3M | Buy |
227,965
+139,754
| +158% | +$795K | ﹤0.01% | 1609 |
|
|
2022
Q2 | $626K | Sell |
88,211
-130
| -0.1% | -$923 | ﹤0.01% | 1771 |
|
|
2022
Q1 | $637K | Buy |
88,341
+17,235
| +24% | +$124K | ﹤0.01% | 1830 |
|
|
2021
Q4 | $635K | Buy |
71,106
+50,716
| +249% | +$453K | ﹤0.01% | 1896 |
|
|
2021
Q3 | $715K | Sell |
20,390
-468,955
| -96% | -$16.4M | ﹤0.01% | 1845 |
|
|
2021
Q2 | $10.5M | Buy |
489,345
+446,979
| +1,055% | +$9.6M | ﹤0.01% | 1256 |
|
|
2021
Q1 | $2.62M | Sell |
42,366
-349
| -0.8% | -$21.6K | ﹤0.01% | 1570 |
|
|
2020
Q4 | $1.78M | Buy |
+42,715
| New | +$1.78M | ﹤0.01% | 1509 |
|